Quantitative Systems Pharmacology in Oncology

Last updated on Nov 6, 2023 1 min read
Image credit: John Moeses Bauan

image

This year’s course in the elective track “Interdisciplinary Oncology” will focus on antibody-drug conjugates. After a general opening session, the following topics will be discussed in the subsequent seminars:

Schedule

  • Various complexities in minimal PBPK models for antibodies with target-mediated drug disposition (TMDD)
  • A platform PBPK model for monoclonal antibodies
  • A full PBPK model for antibody-drug conjugates (ADCs)
  • Tumor growth inhibition by antibody-drug conjugates (ADCs)
  • …
Andreas D. Meid
Andreas D. Meid
Post-doctoral researcher in Clinical Pharmacology & Pharmacoepidemiology

My research interests include the study of appropriate drug therapy using methods of pharmacoepidemiology, quantitative pharmacology, and pharmacometrics.